Recently, however, GLP-1 receptor agonists liraglutide [8] and semaglutide [9] in dosages greater than those used for diabetes provide substantial body weight loss and have generated significant excitement in these and other weight loss therapeutics. Here, GLP1R is linked to diabetes mellitus.